Global Spine Biologics Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2028 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 24.15 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Spine Biologics Market, By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), Surgery Type (Anterior Cervical Discectomy and Fusion (ACDF), Transforamenal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF)), End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Spine Biologics Market
The spine biologics market is expected to witness market growth at a rate of 4.03% in the forecast period of 2021 to 2028. Data Bridge Market Research report on spine biologics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of spine disorders globally is escalating the growth of spine biologics market.
A biologic material refers to a substance which assists in altering the surrounding environment and has an effect on the environment that progresses through an active biological process. These effects can be seen through increased cellular activity, differentiation and growth. Spine biologics comprises of material which is extensively used in the bone fusion surgery, degenerative disc disease and spinal cord injury.
The rise in the cases of degenerative spine disorders and significant increase in treatment rates across the globe act as the major factors driving the growth of spine biologics market. The technological advancements in bone grafting procedures, important role of these biologics in the spine surgery and high demand for minimally invasive procedures accelerate the spine biologics market growth. The high usage of the biomaterials in the treatment of degenerative disc diseases, spinal cord injuries and bone fusion surgeries and high adoption owning to its quick healing, minimum postoperative time and the capability to activate cellular expansion further influence the spine biologics market. Additionally, the growing geriatric population, increasing awareness regarding the newly developed spine treatment techniques, research and development activities and surge in healthcare expenditure positively affect the spine biologics market. Furthermore, development of technologically advanced and cost-effective products extends profitable opportunities to the spine biologics market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the procedure and unfavorable reimbursement scenario is the factors expected to obstruct the spine biologics market growth. The lack of understanding among patients and dearth of expertise and professional knowledge are projected to challenge the spine biologics market in the forecast period of 2021 to 2028.
This spine biologics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on spine biologics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Spine Biologics Market Scope and Market Size
The spine biologics market is segmented on the basis of product, surgery type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the spine biologics market is segmented into bone allografts, bone graft substitute, platelet rich plasma and bone marrow aspirate therapy.
- On the basis of surgery type, the spine biologics market is segmented into anterior cervical discectomy and fusion (ACDF), transforamenal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF) and others.
- On the basis of end-user, the spine biologics market is segmented into hospitals, spinal surgery centers, orthopedic clinics and others.
Global Spine Biologics Market Country Level Analysis
The spine biologics market is analyzed and market size insights and trends are provided by country, product, surgery type and end-user as referenced above.
The countries covered in the spine biologics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the spine biologics market because of the stable economic growth, rising prevalence of spine disorders such as spinal stenosis, disc-related issues and spondylolisthesis and high adoption of minimally invasive surgeries. Asia-Pacific is estimated to witness the fastest growth in the forecast period of 2021-2028 due to the presence of a large patient pool, improvements in infrastructure and healthcare facilities, high prevalence of spine injuries, surge in healthcare expenditure and growth in awareness among surgeons and patients.
The country section of the spine biologics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The spine biologics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for spine biologics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the spine biologics market. The data is available for historic period 2011-2019.
Competitive Landscape and Spine Biologics Market Share Analysis
The spine biologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to spine biologics market.
The major players covered in the spine biologics market report are Arthrex, Inc., Cesca Therapeutics Inc., DePuy Synthes, Orthopaedic Seminar, Exactech, Inc., K2M, Inc., Lattice Biologics Ltd, Medtronic, NuTech Spine, Inc., NuVasive Inc., Orthofix Holdings, Inc., Regen Lab USA LLC, RTI Surgical Holdings, Inc., Stryker, Wright Medical Group N.V., XTANT MEDICAL, Zimmer Biomet, Smith & Nephew, Dr PRP USA LLC among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1. INTRODUCTION
1.1. OVERVIEW OF THE SPINE BIOLOGICS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SPINE BIOLOGICS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL SPINE BIOLOGICS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL SPINE BIOLOGICS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. BONE GROWTH SUBSTITUTES
5.2.1. DEMINERALIZED BONE MATRIX (DBM)
5.2.2. BONE MORPHOGENETIC PROTEINS (BMP)
5.2.3. SYNTHETIC BONE GRAFTS
5.3. BONE ALLOGRAFTS
5.4. PLATELET RICH PLASMA (PRP)
5.5. BONE MARROW ASPIRATE CONCENTRATE (BMAC)
6. SPINE BIOLOGICS MARKET, BY SURGERY TYPE
6.1. OVERVIEW
6.2. ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF)
6.3. TRANSFORAMENAL LUMBAR INTERBODY FUSION (TLIF)
6.4. ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
6.5. LATERAL LUMBAR INTERBODY FUSION (LLIF)
6.6. OTHERS
7. SPINE BIOLOGICS MARKET, BY END USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. SPINAL SURGERY CENTERS
7.4. ORTHOPEDIC CLINICS
7.5. OTHERS
8. SPINE BIOLOGICS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE SPINE BIOLOGICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.1.1. U.S.
8.1.1.2. CANADA
8.1.1.3. MEXICO
8.1.2. EUROPE
8.1.2.1. GERMANY
8.1.2.2. FRANCE
8.1.2.3. U.K.
8.1.2.4. ITALY
8.1.2.5. SPAIN
8.1.2.6. RUSSIA
8.1.2.7. TURKEY
8.1.2.8. BELGIUM
8.1.2.9. NETHERLANDS
8.1.2.10. SWITZERLAND
8.1.2.11. REST OF EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.3.1. JAPAN
8.1.3.2. CHINA
8.1.3.3. SOUTH KOREA
8.1.3.4. INDIA
8.1.3.5. AUSTRALIA
8.1.3.6. SINGAPORE
8.1.3.7. THAILAND
8.1.3.8. MALAYSIA
8.1.3.9. INDONESIA
8.1.3.10. PHILIPPINES
8.1.3.11. REST OF APAC
8.1.4. LATIN AMERICA
8.1.4.1. BRAZIL
8.1.4.2. REST OF LATIN AMERICA
8.1.5. MIDDLE EAST AND AFRICA
8.1.5.1. SOUTH AFRICA
8.1.5.2. REST OF MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. SPINE BIOLOGICS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.2. U.S. SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.4. APAC SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.5. SOUTH AMERICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.6. MIDDLE EAST AND AFRICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.7. MERGERS & ACQUISITIONS
9.8. NEW PRODUCT DEVELOPMENT & APPROVALS
9.9. EXPANSIONS
9.10. REGULATORY CHANGES
9.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. SPINE BIOLOGICS MARKET, COMPANY PROFILES
10.1. APPLIED BIOLOGICS
10.1.1. OVERVIEW
10.1.2. SWOT ANALYSIS
10.1.3. PRODUCT PORTFOLIO
10.1.4. REVENUE ANALYSIS
10.1.5. ANALYSTS VIEW
10.2. ARTHREX, INC.
10.2.1. OVERVIEW
10.2.2. SWOT ANALYSIS
10.2.3. PRODUCT PORTFOLIO
10.2.4. REVENUE ANALYSIS
10.2.5. ANALYSTS VIEW
10.3. CESCA THERAPEUTICS
10.3.1. OVERVIEW
10.3.2. SWOT ANALYSIS
10.3.3. PRODUCT PORTFOLIO
10.3.4. REVENUE ANALYSIS
10.3.5. ANALYST VIEW
10.4. DEPUY SYNTHES
10.4.1. OVERVIEW
10.4.2. SWOT ANALYSIS
10.4.3. PRODUCT PORTFOLIO
10.4.4. REVENUE ANALYSIS
10.4.5. ANALYSTS VIEW
10.5. DMP SPINE
10.5.1. OVERVIEW
10.5.2. SWOT ANALYSIS
10.5.3. PRODUCT PORTFOLIO
10.5.4. REVENUE ANALYSIS
10.5.5. ANALYSTS VIEW
10.6. DR. PRP AMERICA LLC.
10.6.1. OVERVIEW
10.6.2. SWOT ANALYSIS
10.6.3. PRODUCT PORTFOLIO
10.6.4. REVENUE ANALYSIS
10.6.5. ANALYSTS VIEW
10.7. EXACTECH, INC.
10.7.1. OVERVIEW
10.7.2. SWOT ANALYSIS
10.7.3. PRODUCT PORTFOLIO
10.7.4. REVENUE ANALYSIS
10.7.5. ANALYSTS VIEW
10.8. K2M, INC.
10.8.1. OVERVIEW
10.8.2. SWOT ANALYSIS
10.8.3. PRODUCT PORTFOLIO
10.8.4. REVENUE ANALYSIS
10.1.5. ANALYSTS VIEW
10.9. LATTICE BIOLOGICS
10.9.1. OVERVIEW
10.9.2. SWOT ANALYSIS
10.9.3. PRODUCT PORTFOLIO
10.9.4. REVENUE ANALYSIS
10.9.5. ANALYSTS VIEW
10.10. MEDTRONIC
10.10.1. OVERVIEW
10.10.2. SWOT ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. REVENUE ANALYSIS
10.10.5. ANALYSTS VIEW
10.11. NUVASIVE, INC.
10.11.1. OVERVIEW
10.11.2. SWOT ANALYSIS
10.11.3. PRODUCT PORTFOLIO
10.11.4. REVENUE ANALYSIS
10.11.5. ANALYSTS VIEW
10.12. ORTHOFIX HOLDINGS, INC.
10.12.1. OVERVIEW
10.12.2. SWOT ANALYSIS
10.12.3. PRODUCT PORTFOLIO
10.12.4. REVENUE ANALYSIS
10.12.5. ANALYSTS VIEW
10.13. REGENLAB S.A.
10.13.1. OVERVIEW
10.13.2. SWOT ANALYSIS
10.13.3. PRODUCT PORTFOLIO
10.13.4. REVENUE ANALYSIS
10.13.5. ANALYSTS VIEW
10.14. RTI SURGICAL
10.14.1. OVERVIEW
10.14.2. SWOT ANALYSIS
10.14.3. PRODUCT PORTFOLIO
10.14.4. REVENUE ANALYSIS
10.14.5. ANALYSTS VIEW
10.15. STRYKER CORPORATION
10.15.1. OVERVIEW
10.15.2. SWOT ANALYSIS
10.15.3. PRODUCT PORTFOLIO
10.15.4. REVENUE ANALYSIS
10.15.5. ANALYSTS VIEW
10.16. WRIGHT MEDICAL
10.16.1. OVERVIEW
10.16.2. SWOT ANALYSIS
10.16.3. PRODUCT PORTFOLIO
10.16.4. REVENUE ANALYSIS
10.16.5. ANALYSTS VIEW
10.17. X-SPINE SYSTEMS
10.17.1. OVERVIEW
10.17.2. SWOT ANALYSIS
10.17.3. PRODUCT PORTFOLIO
10.17.4. REVENUE ANALYSIS
10.17.5. ANALYSTS VIEW
10.18. ZIMMER BIOMET
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
11. APPENDIX
12. ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
